adalimumab-680lt
Showing 1 - 1 of 1
Crohn Disease, Ulcerative Colitis Trial (Adalimumab-680LT, Control)
Not yet recruiting
- Crohn Disease
- Ulcerative Colitis
- Adalimumab-680LT
- Control
- (no location specified)
Oct 30, 2023